Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Samper Ots PM
- Vallejo Ocana, C.
- Martin Martin M
- Farga Albiol D
- Almendros Blanco P
- Hernandez Machancoses A
- Rico Oses M
- Flamarique Andueza S
- Romero Ruperto F
- Maria Bueno C
- Amaya Escobar E
- Guerrero Gómez LL
- Counago, F.
- Del Pino Alcántara M
- Ruiz Villar MJ
- Monroy Antón JL
- Saez Bueno P
- Luna Tirado J
- Del Mar Puertas M
- Bobo A
- Diaz de Cerio Martínez I
- Gascon Costoso N
- Ferrer Albiach C
Grupos
Abstract
Stereotactic body radiotherapy (SBRT) has become the standard of care for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC) and for patients who refuse surgery. The aim of this study was to evaluate the effectiveness and safety of primary SBRT in patients with early-stage NSCLC.
© 2021. Federación de Sociedades Españolas de Oncología (FESEO).
Datos de la publicación
- ISSN/ISSNe:
- 1699-048X, 1699-3055
- Tipo:
- Article
- Páginas:
- 342-349
- PubMed:
- 34487307
- Factor de Impacto:
- 0,764 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
Clinical & Translational Oncology SPRINGER INT PUBL AG
Citas Recibidas en Web of Science: 6
Documentos
- No hay documentos
Filiaciones
Keywords
- Lung cancer, Prognostic factors, SBRT
Campos de Estudio
Cita
Samper PM,Vallejo C,Martin M,CELADA FJ,Farga D,Almendros P,Hernandez A,Rico M,Flamarique S,Romero F,Maria C,Amaya E,Guerrero LL,Counago F,Del Pino M,Ruiz MJ,Monroy JL,Saez P,Luna J,Del Mar M,Bobo A,Diaz de Cerio Martínez I,Gascon N,Ferrer C. Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society). Clin. Transl. Oncol. 2021. 24. (2):p. 342-349. IF:3,340. (3).
Portal de investigación